BREWIN DOLPHIN LTD - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 194 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
BREWIN DOLPHIN LTD ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$11,000
+12.8%
700.0%0.00%
Q3 2021$9,752
+6.2%
700.0%0.00%
Q2 2021$9,183
-14.0%
700.0%0.00%
-100.0%
Q1 2021$10,672
-41.4%
70
-61.7%
0.00%0.0%
Q4 2020$18,199
+4.3%
1830.0%0.00%0.0%
Q3 2020$17,444
-14.8%
1830.0%0.00%
-50.0%
Q2 2020$20,469
-21.4%
183
-48.9%
0.00%
-33.3%
Q1 2020$26,034
-30.3%
3580.0%0.00%0.0%
Q4 2019$37,336
+4.8%
3580.0%0.00%
-25.0%
Q3 2019$35,635
+70.6%
358
+95.6%
0.00%
+100.0%
Q2 2019$20,889
-9.2%
1830.0%0.00%
-33.3%
Q1 2019$23,005
-7.4%
1830.0%0.00%0.0%
Q4 2018$24,833
-50.6%
1830.0%0.00%
-50.0%
Q3 2018$50,232
+32.5%
1830.0%0.01%
+50.0%
Q2 2018$37,912
+24.8%
183
-0.5%
0.00%0.0%
Q1 2018$30,389
+20.6%
1840.0%0.00%
+33.3%
Q4 2017$25,195
+0.6%
1840.0%0.00%0.0%
Q3 2017$25,0521840.00%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Knott David M Jr 115,000$6,8912.63%
VILLERE ST DENIS J & CO LLC 438,161$26,254,6072.24%
RICE HALL JAMES & ASSOCIATES, LLC 282,961$16,955,0231.08%
Chicago Capital, LLC 360,345$21,591,8841.01%
CARDINAL CAPITAL MANAGEMENT LLC /CT 206,399$12,367,4280.53%
Smith, Graham & Co., Investment Advisors, LP 61,849$3,705,9920.46%
Stephens Investment Management Group LLC 467,564$28,016,4350.46%
Jackson Creek Investment Advisors LLC 13,657$8180.34%
Court Place Advisors, LLC 15,133$906,7690.32%
Ziegler Capital Management, LLC 123,158$7,379,1760.30%
View complete list of LIGAND PHARMACEUTICALS INC shareholders